Trince announces distributor agreement with Meiwafosis

This strategic partnership will significantly bolster our presence in Japan, a global hub for stem cell research and therapies, particularly iPSCs.

By joining forces with Meiwafosis, we aim to expand our commercial footprint and provide Japanese researchers with access to our innovative cell transfection technologies. This collaboration will make cell engineering more gentle and effective, empowering groundbreaking advancements in the field.
Stay tuned for more updates as we embark on this exciting journey together!